Emerald Bioscience Stock Earnings Per Share
Emerald Bioscience fundamentals help investors to digest information that contributes to Emerald Bioscience's financial success or failures. It also enables traders to predict the movement of Emerald OTC Stock. The fundamental analysis module provides a way to measure Emerald Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emerald Bioscience otc stock.
Emerald |
Emerald Bioscience OTC Stock Earnings Per Share Analysis
Emerald Bioscience's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Emerald Bioscience Earnings Per Share | (0.16) X |
Most of Emerald Bioscience's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emerald Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Emerald Bioscience has an Earnings Per Share of -0.158 times. This is 101.89% lower than that of the Healthcare sector and 96.7% lower than that of the Biotechnology industry. The earnings per share for all United States stocks is 105.06% higher than that of the company.
Emerald Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emerald Bioscience's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emerald Bioscience could also be used in its relative valuation, which is a method of valuing Emerald Bioscience by comparing valuation metrics of similar companies.Emerald Bioscience is currently under evaluation in earnings per share category among related companies.
Emerald Fundamentals
| Return On Equity | -740.91 | |||
| Return On Asset | -224.1 | |||
| Current Valuation | 86.55 M | |||
| Shares Outstanding | 133.91 M | |||
| Shares Owned By Insiders | 59.50 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (0.62) X | |||
| Price To Book | (9.09) X | |||
| Revenue | 399.91 K | |||
| Gross Profit | 166.22 K | |||
| EBITDA | (4.51 M) | |||
| Net Income | (19.19 M) | |||
| Cash And Equivalents | 1.85 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.36 M | |||
| Debt To Equity | (2.11) % | |||
| Current Ratio | 0.12 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (3.94 M) | |||
| Earnings Per Share | (0.16) X | |||
| Beta | -0.04 | |||
| Market Capitalization | 87.04 M | |||
| Total Asset | 692 K | |||
| Retained Earnings | (9.84 M) | |||
| Working Capital | (206 K) | |||
| Current Asset | 635 K | |||
| Current Liabilities | 841 K | |||
| Z Score | -1.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Bioscience's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |